Cargando…

A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series

BACKGROUND: Iluvien(®) is a novel, nonbiodegradable, sustained-release drug delivery system (0.2 μg/d fluocinolone acetonide [FAc]) indicated in Europe for the treatment of vision impairment associated with chronic diabetic macular edema (DME), considered insufficiently responsive to available thera...

Descripción completa

Detalles Bibliográficos
Autor principal: Schmit-Eilenberger, Vera K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427264/
https://www.ncbi.nlm.nih.gov/pubmed/25999689
http://dx.doi.org/10.2147/OPTH.S79785